Literature DB >> 20865654

Reproductive aging, sexuality and symptoms.

Judi L Chervenak1.   

Abstract

Female sexual dysfunction (FSD) affects ~50% of postmenopausal women. Unfortunately, it often goes undiagnosed because both patients and health-care providers may be reluctant to bring it up at an annual office visit. FSD encompasses both physical and emotional components, all of which are often intermingled. Exhaustion, anxiety, stress, interpersonal relationship issues, hormonal changes and their sequelae on vaginal tissue, medication side effects, and medical problems all play a potential role. This review discusses some of the common etiologies and diagnostic and management options. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865654     DOI: 10.1055/s-0030-1262897

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  3 in total

1.  Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction.

Authors:  E Maseroli; E Fanni; M Fambrini; B Ragghianti; E Limoncin; E Mannucci; M Maggi; L Vignozzi
Journal:  J Endocrinol Invest       Date:  2015-09-03       Impact factor: 4.256

2.  Sexual behaviors among adults in Puerto Rico: a population-based study.

Authors:  Ana Patricia Ortiz; Marievelisse Soto-Salgado; Erick Suárez; María del Carmen Santos-Ortiz; Guillermo Tortolero-Luna; Cynthia M Pérez
Journal:  J Sex Med       Date:  2011-06-15       Impact factor: 3.802

3.  Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.

Authors:  David J Portman; Andrew M Kaunitz; Kazem Kazempour; Hana Mekonnen; Sailaja Bhaskar; Joel Lippman
Journal:  Menopause       Date:  2014-10       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.